Keyphrases
Human Leukocyte Antigen Class I
100%
Class I Alleles
100%
Melanocytic Tumor
100%
Melanoma
87%
Immunogenicity
87%
Human Leukocyte Antigen
75%
Melanoma Antigens
75%
Binding Affinity
62%
Epitope
37%
Beneficial Outcomes
25%
New Human Leukocyte Antigen Allele
25%
Immunogenetics
25%
Human Immune System
25%
Immune Checkpoint Blockade
12%
Antigenic Epitope
12%
Tumor Elimination
12%
T Cell Response
12%
Immunogenic Epitopes
12%
GC Gene
12%
In Silico Methods
12%
Human Leukocyte antigen-B
12%
Human Leukocyte antigen-C
12%
Checkpoint Blockade Immunotherapy
12%
Transient Receptor Potential Vanilloid 1 (TRPV1)
12%
Tumor Antigen
12%
Tyrosinase
12%
Cancer Cells
12%
Effective Engagement
12%
S100
12%
Freely Available
12%
TRP-2
12%
In Silico
12%
Nonamers
12%
CD8+ T Lymphocytes
12%
Beneficial Effects
12%
SSX2
12%
Immune Checkpoint Inhibitors
12%
I to
12%
Medicine and Dentistry
Melanoma
50%
Neoplasm
50%
Human Leukocyte Antigen
50%
Allele
50%
Binding Affinity
21%
Immunogenicity
21%
Melanoma Antigen
21%
Epitope
14%
Tumor Antigen
7%
Immunotherapy
7%
Tyrosinase
7%
Immune Response
7%
Immunogenetics
7%
Prevalence
7%
In Silico
7%
Immune Checkpoint Inhibitor
7%
Lymphocyte
7%
CD8 Antigen
7%
Immunology and Microbiology
Human Leukocyte Antigen
50%
Immunogenicity
50%
Allele
50%
Immunology
50%
Epitope
21%
Melanoma Antigen
21%
Binding Affinity
14%
Immunotherapy
14%
Immunogenetics
7%
Immune Checkpoint Blockade
7%
T Cell
7%
Prevalence
7%
Immune Response
7%